106 related articles for article (PubMed ID: 16617553)
1. Hepatitis A prevalence among injection drug users.
Wells R; Fisher D; Fenaughty A; Cagle H; Jaffe A
Clin Lab Sci; 2006; 19(1):12-7. PubMed ID: 16617553
[TBL] [Abstract][Full Text] [Related]
2. Past infection with hepatitis A virus among Vancouver street youth, injection drug users and men who have sex with men: implications for vaccination programs.
Ochnio JJ; Patrick D; Ho M; Talling DN; Dobson SR
CMAJ; 2001 Aug; 165(3):293-7. PubMed ID: 11517645
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of HIV and hepatitis B and self-reported injection risk behavior during detention among street-recruited injection drug users in Los Angeles County, 1994-1996.
López-Zetina J; Kerndt P; Ford W; Woerhle T; Weber M
Addiction; 2001 Apr; 96(4):589-95. PubMed ID: 11300962
[TBL] [Abstract][Full Text] [Related]
4. Validity of injecting drug users' self report of hepatitis A, B, and C.
Schlicting EG; Johnson ME; Brems C; Wells RS; Fisher DG; Reynolds G
Clin Lab Sci; 2003; 16(2):99-106. PubMed ID: 12757189
[TBL] [Abstract][Full Text] [Related]
5. The role of injection versus socioeconomic factors in hepatitis A virus infection among young heroin users: Implications for vaccination policies.
Luquero FJ; Vallejo F; Fuente Lde L; Toro C; Brugal MT; Bravo MJ; Soriano V; Barrio G; Pulido J;
Vaccine; 2009 May; 27(20):2674-9. PubMed ID: 19428878
[TBL] [Abstract][Full Text] [Related]
6. Demographic characteristics and risk behaviors associated with HIV positive injecting drug users in Xinjiang, China.
Zhang Y; Shan H; Trizzino J; Ruan Y; Beauchamp G; Mâsse B; Ma J; Gu Y; He Y; Rui B; Wang J; Poundstone K; Jiang Y; Brooks Jackson J; Shao Y
J Infect; 2007 Mar; 54(3):285-90. PubMed ID: 16831464
[TBL] [Abstract][Full Text] [Related]
7. Multiple viral hepatitis in injection drug users and associated risk factors.
Reimer J; Lorenzen J; Baetz B; Fischer B; Rehm J; Haasen C; Backmund M
J Gastroenterol Hepatol; 2007 Jan; 22(1):80-5. PubMed ID: 17201886
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of and risk factors for hepatitis B virus infection among street-recruited young injection and non-injection heroin users in Barcelona, Madrid and Seville.
Vallejo F; Toro C; de la Fuente L; Brugal MT; Soriano V; Silva TC; Bravo MJ; Ballesta R; Barrio G;
Eur Addict Res; 2008; 14(3):116-24. PubMed ID: 18552487
[TBL] [Abstract][Full Text] [Related]
9. Twenty years of selective hepatitis B vaccination: is hepatitis B declining among injecting drug users in England and Wales?
Judd A; Hickman M; Hope VD; Sutton AJ; Stimson GV; Ramsay ME; Gill ON; Parry JV
J Viral Hepat; 2007 Aug; 14(8):584-91. PubMed ID: 17650293
[TBL] [Abstract][Full Text] [Related]
10. HIV prevalence among injection drug users in rural Guangxi China.
Liu W; Chen J; Rodolph M; Beauchamp G; Mâsse B; Wang S; Li R; Ruan Y; Zhou F; Leung MK; Lai S; Shao Y; Jackson JB
Addiction; 2006 Oct; 101(10):1493-8. PubMed ID: 16968351
[TBL] [Abstract][Full Text] [Related]
11. Young adult injection drug users in the United States continue to practice HIV risk behaviors.
Rondinelli AJ; Ouellet LJ; Strathdee SA; Latka MH; Hudson SM; Hagan H; Garfein RS
Drug Alcohol Depend; 2009 Sep; 104(1-2):167-74. PubMed ID: 19559543
[TBL] [Abstract][Full Text] [Related]
12. The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994-2004.
Holtzman D; Barry V; Ouellet LJ; Des Jarlais DC; Vlahov D; Golub ET; Hudson SM; Garfein RS
Prev Med; 2009 Aug; 49(1):68-73. PubMed ID: 19410600
[TBL] [Abstract][Full Text] [Related]
13. Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT).
Garfein RS; Swartzendruber A; Ouellet LJ; Kapadia F; Hudson SM; Thiede H; Strathdee SA; Williams IT; Bailey SL; Hagan H; Golub ET; Kerndt P; Hanson DL; Latka MH;
Drug Alcohol Depend; 2007 Nov; 91 Suppl 1():S4-17. PubMed ID: 17582705
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran.
Zamani S; Ichikawa S; Nassirimanesh B; Vazirian M; Ichikawa K; Gouya MM; Afshar P; Ono-Kihara M; Ravari SM; Kihara M
Int J Drug Policy; 2007 Oct; 18(5):359-63. PubMed ID: 17854723
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of atopy in children with antibodies against hepatitis A virus and hepatitis B virus.
Kocabaş E; Yapicioğlu H; Yildizdaş D; Güneşer Kendirli S; Burgut R
Turk J Pediatr; 2006; 48(3):189-96. PubMed ID: 17172060
[TBL] [Abstract][Full Text] [Related]
16. A prevalence study of hepatitis A virus infection in a migrant community: Is hepatitis A vaccine indicated?
Dentinger CM; Heinrich NL; Bell BP; Fox LM; Katz DJ; Culver DH; Shapiro CN
J Pediatr; 2001 May; 138(5):705-9. PubMed ID: 11343047
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of hepatitis B and C among HIV positive patients in Georgia and its associated risk factors.
Badridze N; Chkhartishvili N; Abutidze A; Gatserelia L; Sharvadze L
Georgian Med News; 2008 Dec; (165):54-60. PubMed ID: 19124918
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of hepatitis B, tetanus, hepatitis A, human immunodeficiency virus and feasibility of vaccine delivery among injecting drug users in Bangkok, Thailand, 2003-2005.
Sunthornchart S; Linkins RW; Natephisarnwanish V; Levine WC; Maneesinthu K; Lolekha R; Tappero JW; Trirat N; Muktier S; Chancharastong P; Fox K; Donchalermpak S; Vitek C; Supawitkul S
Addiction; 2008 Oct; 103(10):1687-95. PubMed ID: 18705685
[TBL] [Abstract][Full Text] [Related]
19. Background demographics and risk behaviors of injecting drug users in Karachi, Pakistan.
Parviz S; Fatmi Z; Altaf A; McCormick JB; Fischer-Hoch S; Rahbar M; Luby S
Int J Infect Dis; 2006 Sep; 10(5):364-71. PubMed ID: 16793307
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence of hepatitis A virus infection in persons with HIV infection in Taiwan: implications for hepatitis A vaccination.
Sun HY; Kung HC; Ho YC; Chien YF; Chen MY; Sheng WH; Hsieh SM; Wu CH; Liu WC; Hung CC; Chang SC
Int J Infect Dis; 2009 Sep; 13(5):e199-205. PubMed ID: 19208490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
